Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Avanos Medical (AVNS) EPS (Basic) (2016 - 2026)

Avanos Medical's EPS (Basic) history spans 13 years, with the latest figure at -$0.02 for Q4 2025.

  • On a quarterly basis, EPS (Basic) rose 99.77% to -$0.02 in Q4 2025 year-over-year; TTM through Dec 2025 was -$1.57, a 81.72% increase, with the full-year FY2025 number at -$1.57, up 81.59% from a year prior.
  • EPS (Basic) hit -$0.02 in Q4 2025 for Avanos Medical, up from -$0.03 in the prior quarter.
  • Over the last five years, EPS (Basic) for AVNS hit a ceiling of $0.8 in Q2 2021 and a floor of -$8.76 in Q4 2024.
  • Historically, EPS (Basic) has averaged -$0.54 across 5 years, with a median of $0.02 in 2024.
  • Biggest five-year swings in EPS (Basic): skyrocketed 1433.33% in 2021 and later plummeted 4250.0% in 2025.
  • Tracing AVNS's EPS (Basic) over 5 years: stood at $0.24 in 2021, then dropped by 12.5% to $0.21 in 2022, then increased by 9.52% to $0.23 in 2023, then crashed by 3908.7% to -$8.76 in 2024, then surged by 99.77% to -$0.02 in 2025.
  • Business Quant data shows EPS (Basic) for AVNS at -$0.02 in Q4 2025, -$0.03 in Q3 2025, and -$1.66 in Q2 2025.